211 related articles for article (PubMed ID: 22190700)
1. Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells.
Roti Roti EC; Salih SM
Biol Reprod; 2012 Mar; 86(3):96. PubMed ID: 22190700
[TBL] [Abstract][Full Text] [Related]
2. Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary.
Salih SM; Ringelstetter AK; Elsarrag MZ; Abbott DH; Roti EC
Biol Reprod; 2015 Mar; 92(3):73. PubMed ID: 25609833
[TBL] [Abstract][Full Text] [Related]
3. Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice.
Kropp J; Roti Roti EC; Ringelstetter A; Khatib H; Abbott DH; Salih SM
PLoS One; 2015; 10(11):e0142588. PubMed ID: 26544188
[TBL] [Abstract][Full Text] [Related]
4. Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent.
Roti Roti EC; Leisman SK; Abbott DH; Salih SM
PLoS One; 2012; 7(8):e42293. PubMed ID: 22876313
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice.
Roti Roti EC; Ringelstetter AK; Kropp J; Abbott DH; Salih SM
PLoS One; 2014; 9(9):e108174. PubMed ID: 25251158
[TBL] [Abstract][Full Text] [Related]
6. Dexrazoxane does not mitigate early vascular toxicity induced by doxorubicin in mice.
Bosman M; Krüger DN; Favere K; De Meyer GRY; Franssen C; Van Craenenbroeck EM; Guns PJ
PLoS One; 2023; 18(11):e0294848. PubMed ID: 38015959
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.
Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF
Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Hofland KF; Thougaard AV; Sehested M; Jensen PB
Clin Cancer Res; 2005 May; 11(10):3915-24. PubMed ID: 15897593
[TBL] [Abstract][Full Text] [Related]
10. Dexrazoxane does not protect against doxorubicin-induced damage in young rats.
Héon S; Bernier M; Servant N; Dostanic S; Wang C; Kirby GM; Alpert L; Chalifour LE
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H499-506. PubMed ID: 12714334
[TBL] [Abstract][Full Text] [Related]
11. TOP2β is essential for ovarian follicles that are hypersensitive to chemotherapeutic drugs.
Zhang YL; Yu C; Ji SY; Li XM; Zhang YP; Zhang D; Zhou D; Fan HY
Mol Endocrinol; 2013 Oct; 27(10):1678-91. PubMed ID: 24002654
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin.
Yan T; Deng S; Metzger A; Gödtel-Armbrust U; Porter AC; Wojnowski L
Mol Cancer Ther; 2009 May; 8(5):1075-85. PubMed ID: 19417146
[TBL] [Abstract][Full Text] [Related]
13. DNA damage is an early event in doxorubicin-induced cardiac myocyte death.
L'Ecuyer T; Sanjeev S; Thomas R; Novak R; Das L; Campbell W; Heide RV
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1273-80. PubMed ID: 16565313
[TBL] [Abstract][Full Text] [Related]
14. Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro.
Sanchez AM; Giorgione V; Viganò P; Papaleo E; Candiani M; Mangili G; Panina-Bordignon P
Toxicol Sci; 2013 Nov; 136(1):183-92. PubMed ID: 23956100
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
[TBL] [Abstract][Full Text] [Related]
16. The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells.
Hasinoff BB; Yalowich JC; Ling Y; Buss JL
Anticancer Drugs; 1996 Jul; 7(5):558-67. PubMed ID: 8862724
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
18. Dexrazoxane exacerbates doxorubicin-induced testicular toxicity.
Levi M; Tzabari M; Savion N; Stemmer SM; Shalgi R; Ben-Aharon I
Reproduction; 2015 Oct; 150(4):357-66. PubMed ID: 26329125
[TBL] [Abstract][Full Text] [Related]
19. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
Herman EH; Zhang J; Rifai N; Lipshultz SE; Hasinoff BB; Chadwick DP; Knapton A; Chai J; Ferrans VJ
Cancer Chemother Pharmacol; 2001 Oct; 48(4):297-304. PubMed ID: 11710630
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
